Decreasing rates of invasive candidiasis in pediatric hospitals across the United States

Clinical Infectious Diseases

Volumn 58, Issue 1, 2014, Pages 74-77

  Fisher, Brian T ^a,b   Ross, Rachael K ^a   Localio, A Russell ^a,b,c   Prasad, Priya A ^a   Zaoutis, Theoklis E ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Center for Clinical Epidemiology and Biostatistics   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

candidiasis; mortality; pediatrics

Indexed keywords

FLUCONAZOLE;

ADULT; ARTICLE; CANDIDEMIA; CATHETER INFECTION; CROSS-SECTIONAL STUDY; HUMAN; INFECTION CONTROL; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PEDIATRIC HOSPITAL; POPULATION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; UNITED STATES; YOUNG ADULT;

CANDIDIASIS; MORTALITY; PEDIATRICS;

ADOLESCENT; CANDIDIASIS, INVASIVE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; MALE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84891353972     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit679     Document Type: Article

References (12)

1. Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167:1247-51.
2. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-44.
3. Fisher BT, Zaoutis TE. Treatment of invasive candidiasis in immunocompromised pediatric patients. Paediatr Drugs 2008; 10:281-98.
4. Bodey GP. The emergence of fungi as major hospital pathogens. J Hosp Infect 1988; 11(suppl A):411-26.
5. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005; 41:1232-9.
6. Ota KV, McGowan KL. Declining incidence of candidemia in a tertiary inpatient pediatric population. J Clin Microbiol 2012; 50: 1048-50.
7. Chitnis AS, Magill SS, Edwards JR, Chiller TM, Fridkin SK, Lessa FC. Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. Pediatrics 2012; 130:e46-52.
8. Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from populationbased laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55:1352-61.
9. Averill RF, Goldfield N, Hughes JS, et al. All patient refined diagnosis related groups (APR-DRG) classification system, version 26.1: methodology overview. 3M Information Systems,Wallingford, CT: 2008: 1-98.
10. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-35.
11. Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60:243-8.
12. Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012; 54:1110-22.